Genmab AS Net Asset Quality Index

Latest as of December 2025: 45.4%

Genmab AS net asset quality index. Genmab AS (GMAB) has a Net Asset Quality Index of 45.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $12.84 Billion minus total liabilities of $7.01 Billion yields net assets of $5.83 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check GMAB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Quality Index

45.4%
Equity / Total Assets

Net Assets

$5.83 Billion
USD

Total Assets

$12.84 Billion
USD

Total Liabilities

$7.01 Billion
USD

Net Asset Quality Index of Genmab AS (2002–2025)

Net asset quality index of Genmab AS from 2002 to 2025. This chart shows how Genmab AS's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 45.4%, representing net assets of $5.83 Billion against total assets of $12.84 Billion USD. See Genmab AS (GMAB) shareholders funds for net asset value and shareholders' equity analysis.

Genmab AS Net Asset Quality Index by Year (2002–2025)

Genmab AS net asset quality index by year from 2002 to 2025. The table below presents the year-by-year Net Asset Quality Index for Genmab AS from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Genmab AS market cap and net worth.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 45.4% $5.83 Billion $12.84 Billion $7.01 Billion ▼ -34.7 pp
2024 80.1% $36.70 Billion $45.81 Billion $9.11 Billion ▼ -9.5 pp
2023 89.6% $31.61 Billion $35.29 Billion $3.68 Billion ▼ -1.0 pp
2022 90.6% $27.28 Billion $30.12 Billion $2.84 Billion ▲ +0.5 pp
2021 90.1% $22.20 Billion $24.63 Billion $2.43 Billion ▼ -0.3 pp
2020 90.4% $19.12 Billion $21.14 Billion $2.02 Billion ▼ -2.3 pp
2019 92.8% $14.05 Billion $15.14 Billion $1.10 Billion ▼ -2.0 pp
2018 94.7% $8.01 Billion $8.46 Billion $446.64 Million ▼ -0.3 pp
2017 95.0% $6.27 Billion $6.60 Billion $330.75 Million ▲ +2.8 pp
2016 92.1% $4.83 Billion $5.24 Billion $411.54 Million ▲ +2.8 pp
2015 89.3% $3.49 Billion $3.90 Billion $415.83 Million ▲ +18.4 pp
2014 70.9% $2.03 Billion $2.87 Billion $833.74 Million ▲ +32.8 pp
2013 38.1% $659.52 Million $1.73 Billion $1.07 Billion ▲ +15.5 pp
2012 22.6% $383.19 Million $1.69 Billion $1.31 Billion ▼ -8.5 pp
2011 31.1% $486.42 Million $1.56 Billion $1.08 Billion ▼ -12.4 pp
2010 43.5% $1.08 Billion $2.48 Billion $1.40 Billion ▼ -14.9 pp
2009 58.4% $1.30 Billion $2.22 Billion $924.34 Million ▼ -8.8 pp
2008 67.2% $2.19 Billion $3.26 Billion $1.07 Billion ▼ -5.7 pp
2007 72.8% $2.88 Billion $3.96 Billion $1.08 Billion ▼ -16.2 pp
2006 89.1% $1.61 Billion $1.80 Billion $197.05 Million ▲ +7.4 pp
2005 81.6% $1.12 Billion $1.37 Billion $251.66 Million ▼ -11.2 pp
2004 92.9% $1.18 Billion $1.27 Billion $90.92 Million ▲ +0.8 pp
2003 92.1% $1.09 Billion $1.18 Billion $93.67 Million ▲ +3.7 pp
2002 88.4% $1.40 Billion $1.58 Billion $183.97 Million —
pp = percentage points